EconPapers    
Economics at your fingertips  
 

Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases

B.E. Riley, J.C. Lougheed, K. Callaway, M. Velasquez, E. Brecht, L. Nguyen, T. Shaler, D. Walker, Y. Yang, K. Regnstrom, L. Diep, Z. Zhang, S. Chiou, M. Bova, D.R. Artis, N. Yao, J. Baker, T. Yednock and J.A. Johnston ()
Additional contact information
B.E. Riley: Elan Pharmaceuticals
J.C. Lougheed: Elan Pharmaceuticals
K. Callaway: Elan Pharmaceuticals
M. Velasquez: Elan Pharmaceuticals
E. Brecht: Elan Pharmaceuticals
L. Nguyen: Elan Pharmaceuticals
T. Shaler: SRI International
D. Walker: Elan Pharmaceuticals
Y. Yang: Elan Pharmaceuticals
K. Regnstrom: Elan Pharmaceuticals
L. Diep: Elan Pharmaceuticals
Z. Zhang: Elan Pharmaceuticals
S. Chiou: Elan Pharmaceuticals
M. Bova: Elan Pharmaceuticals
D.R. Artis: Elan Pharmaceuticals
N. Yao: Elan Pharmaceuticals
J. Baker: Elan Pharmaceuticals
T. Yednock: Elan Pharmaceuticals
J.A. Johnston: Elan Pharmaceuticals

Nature Communications, 2013, vol. 4, issue 1, 1-9

Abstract: Abstract Parkin is a RING-between-RING E3 ligase that functions in the covalent attachment of ubiquitin to specific substrates, and mutations in Parkin are linked to Parkinson’s disease, cancer and mycobacterial infection. The RING-between-RING family of E3 ligases are suggested to function with a canonical RING domain and a catalytic cysteine residue usually restricted to HECT E3 ligases, thus termed ‘RING/HECT hybrid’ enzymes. Here we present the 1.58 Å structure of Parkin-R0RBR, revealing the fold architecture for the four RING domains, and several unpredicted interfaces. Examination of the Parkin active site suggests a catalytic network consisting of C431 and H433. In cells, mutation of C431 eliminates Parkin-catalysed degradation of mitochondria, and capture of an ubiquitin oxyester confirms C431 as Parkin’s cellular active site. Our data confirm that Parkin is a RING/HECT hybrid, and provide the first crystal structure of an RING-between-RING E3 ligase at atomic resolution, providing insight into this disease-related protein.

Date: 2013
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/ncomms2982 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms2982

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/ncomms2982

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms2982